The post BAT Technical Analysis Feb 23 appeared on BitcoinEthereumNews.com. [ENGLISH: BAT market structure clearly dominated by downtrend; recent lower high andThe post BAT Technical Analysis Feb 23 appeared on BitcoinEthereumNews.com. [ENGLISH: BAT market structure clearly dominated by downtrend; recent lower high and

BAT Technical Analysis Feb 23

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

[ENGLISH: BAT market structure clearly dominated by downtrend; recent lower high and lower low formations signal trend continuation, but a breakout above the $0.1255 level could provide a structural change signal.]

Market Structure Overview

The current market structure of the BAT token reflects a clear downtrend. Price is trading at the $0.12 level, squeezed in the $0.11-$0.12 range with a 2.68% drop over the last 24 hours. In structural analysis, the lower highs/lower lows (LH/LL) pattern is dominant instead of higher highs/higher lows (HH/HL); this indicates continuation of bearish momentum. Trading below short-term EMA20 ($0.13), combined with Supertrend’s bearish signal, keeps the overall structure weak. In multi-timeframe (MTF) examination, a total of 11 strong levels were identified across 1D, 3D, and 1W charts: 1 support/2 resistance on 1D, 2 support/3 resistance on 3D, 3 support/4 resistance on 1W weighted. RSI at 33.53 approaching oversold region, despite positive MACD histogram, overall structure bearish. This configuration requires a strong Change of Character (CHoCH) for trend reversal.

Trend Analysis: Uptrend or Downtrend?

Uptrend Signals

Ideal HH/HL structure for uptrend not observed; recent swing highs progressively lower (descent from $0.1255 to $0.1210). However, positive MACD histogram and RSI at 33.53 giving bottom signal carry short-term bounce potential. Break of $0.1255 resistance (Break of Structure – BOS) could confirm HL structure by forming a new higher high and open $0.1673 target. For now, these signals are weak; bullish continuation remains limited as long as price stays below EMA20. Educational note: HH/HL requires consecutive higher swing points for trend continuation – not yet formed in BAT.

Downtrend Risk

Downtrend strongly confirmed with LH/LL: Latest swing low $0.0969, lowering previous lows to reinforce bearish structure. Price below $0.13 EMA, Supertrend resistance at $0.14 applying pressure. MTF shows abundance of resistances (9R vs 6S), increasing downward bias. Break of $0.0969 triggers new LL with $0.0410 bearish target. Though RSI low, no bearish divergence; trend continuation likely. To watch: If LH formation confirmed around $0.1210, downside accelerates.

Structure Break (BOS) Levels

Structural breaks (BOS) confirm trend changes. Critical level for bullish BOS is $0.1255 (score 69/100) – latest swing high and strong resistance. Breakout + close invalidates LH and signals transition to HH/HL; target $0.1673. Bearish BOS is $0.0969 support break (score 69/100) – becomes bearish CHoCH with new LL, opens path to $0.0410. Intermediate resistance $0.1210 (score 67/100), local LH as bearish filter. Educational: BOS defines structure shift by breaking previous swing point; in BAT, no bullish BOS yet, bearish risk high. $0.14 Supertrend also major resistance.

Swing Points and Their Importance

Recent Swing Highs

Recent swing highs: $0.1255 (main resistance, LH1), $0.1210 (secondary LH2). These points mark LH legs of downtrend; sell pressure increases on return to here. If $0.1255 not broken, LH/LL continuation confirmed. Importance: These levels ideal invalidation points for short positions – BOS above long trigger.

Recent Swing Lows

Latest swing low $0.0969 (critical support, LL), strong with score 69/100. If held here, provides base for local HL formation; if broken, cascade lows expected. Lower position relative to previous lows strengthens bearish structure. Educational: Swing points define fractal structure – in BAT, LL dominance requires $0.1255+ BOS for reversal.

Bitcoin Correlation

BTC at $65,842 with 3.23% drop in downtrend; Supertrend bearish, supports $64,009/$62,484/$60,000, resistances $65,867/$68,221/$70,910. BAT, highly correlated altcoin with BTC; BTC downside amplifies effect on alts. If BTC breaks below $64K, accelerates BAT $0.0969 test. Conversely, BTC $65,867 BOS supports BAT $0.1255 rally. Rising dominance (BTC bearish caution) further weakens BAT structure – BTC key levels critical for filtering BAT trades.

Structural Outlook and Expectations

Overall structural outlook bearish: LH/LL downtrend dominant, $0.12 price in squeeze. Continuation requires $0.0969 break, reversal requires $0.1255 BOS. MTF resistance superiority requires caution despite short-term bounces. Trade suggestion: Follow structure in BAT Spot Analysis and BAT Futures Analysis. No news, stay pure structure-focused. Overall, structure neutral-bearish; CHoCH awaited.

This analysis uses Chief Analyst Devrim Cacal’s market views and methodology.

Trading Analyst: Emily Watson

Short-term trading strategies expert

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/bat-technical-analysis-february-23-2026-market-structure

Market Opportunity
BAT Logo
BAT Price(BAT)
$0.0987
$0.0987$0.0987
+0.61%
USD
BAT (BAT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09